Back
 
Scroll
HISTORY &
MILESTONE
learn more +
BOARD OF
DIRECTORS
  • HUSEIN ESUFALLY

    Non-Executive Chairman

    -

    Mr. Husein Esufally started his career with the Group's FMCG (Fast Moving Consumer Goods) business, where he steered the Company for a period of 19 years, during which, the business established a strong consumer franchise. Thereafter, he served for 13 years as the Chief Executive Officer of the Hemas Group until he relinquished his position in March 2014. Presently, he serves as the Non-Executive Chairman of Hemas Holdings PLC, whilst also chairing the Boards of its FMCG and pharmaceutical manufacturing subsidiaries. Mr. Esufally is presently the Non-Executive Chairman of Janashakthi Insurance PLC. He also serves on the Boards of several other companies and is involved in several social projects. Mr. Esufally holds a Bachelor of Science (Honours) Degree in Electronics from the University of Sussex, UK having received his primary education at St. Thomas College, Mt Lavinia.

  • STEVEN ENDERBY

    Director/CEO

    -

    Mr. Steven Enderby joined Hemas in March 2013 to head the Group's efforts in Mergers and Acquisitions. He took up the Office of Deputy CEO and Director of Hemas Holdings PLC in November 2013 and was appointed the Chief Executive Officer of the Company on 01st April 2014. Mr. Enderby has had a successful track record in the private equity space with Actis, a leading global emerging markets fund, until his retirement in 2011 as an Actis Partner. Some of the most successful private equity transactions he led include South Asia Gateway Terminal. Ceylon Oxygen and Millennium Information Technologies. He has also served on the Boards of leading companies in Sri Lanka and India such as John Keells Holdings, Lion Brewery and Punjab Tractors. He is a Fellow of the Chartered Institute of Management Accountants, and holds a Degree in Economics and Accounting from Queens University Belfast, and a Master's Degree in Development Studies from the University of Melbourne.

  • Kasturi Chellaraja Wilson

    Director/Deputy CEO

    -

    Kasturi is the Managing Director of Hemas Pharmaceuticals and the Group’s Logistics and Maritime sectors. She is a Fellow of the Chartered Institute of Management Accountants, UK and has served as Board Member of CIMA, Sri Lanka. She counts for over 29 years of managerial experience in multiple industries and functions spanning from auditing, consulting, logistics, leisure and travel and pharmaceuticals. Kasturi joined Hemas in 2002 as the Finance Director of Hemtours (Presently, Diethelm Travel) and in 2005 she was appointed the Head of Shared Services for the Group and subsequently as the Chief Process Officer of the Group in 2007. In 2011 she was appointed as the Managing Director of the Transportation Sector and in 2016, Managing Director of the Pharmaceutical Distribution Business. In 2017 she was appointed a Non-Independent Non-Executive Director of Morison PLC and in 2018 as a Non-Executive of Capital Alliance Ltd. Kasturi is also a member of the Economic Policy Committee of the Ceylon Chamber of Commerce.

  • ABBAS ESUFALLY

    Non-Executive Director

    -

    With over 35 years' experience in the Tourism industry, Mr. Abbas Esufally has played a pivotal role in expanding the Group's Leisure interest, He serves as a Group Director of Hemas Holdings PLC, Chairman of Serendib Hotels PLC, Dolphin Hotels PLC, Hotel Sigiriya PLC as well as Diethelm Travel Sri Lanka (Pvt) Ltd, Sri Lanka's premier Destination Management Company. He also serves on several other listed and unlisted company boards. He has played an active part in the growth and development of the country's Tourism industry. Mr. Esufally serves as the Chairman of the Mercantile Service Provident Society of the Ceylon Chamber of Commerce and is a Member of the Advisory Committee of the Tourist Hotels Association of Sri Lanka and a Member of the Advisory Council appointed by the Hon. Minister of Tourism. Mr. Esufally is a Fellow Member of both the Institute of Chartered Accountants of England & Wales and the Institute of Chartered Accountants of Sri Lanka. He is an all Island Justice of Peace and serves as the Honorary Consul of Bhutan in Sri Lanka.

  • MURTAZA ESUFALLY

    Executive Director

    -

    Mr. Murtaza Esufally counts more than 25 years of experience in senior management levels. He is the Chairman of Hemas Hospitals (Pvt) Ltd and Hemas Pharmaceuticals (Pvt) Ltd, and is the Non-Executive Chairman of the Centre for Poverty Analysis. He holds a Master's Degree in Business Administration from the Melbourne Business School of the University of Melbourne, He is a Barrister of the Lincoln's Inn and holds a Bachelor of Law Degree from the University of Essex, UK. Mr. Esufally is an Attorney-at-Law of the Supreme Court of Sri Lanka.

  • IMTIAZ ESUFALLY

    Non-Executive Director

    -

    Mr. Imtiaz Esufally serves as the Chairman of the Transportation Sector of the Group and serves as a Member of the Hemas Audit Committee. He served as the Chairman of Hemas Power PLC until its disposal in 2014. Mr. Esufally holds a Bachelor of Arts (Honours) Degree in Accounting and Economics from the University of Kent, UK. He counts over 25 years of management experience and has been in the forefront of the Transportation industry in Sri Lanka.

  • RAMABADRAN GOPALAKRISHNAN

    Independent Director

    -

    Mr. Ramabadran Gopalakrishnan has over 48 years of experience in professional management with 31 years in Unilever and 17 years in TATA. He has served as Chairman of Unilever Arabia, as Managing Director of Brooke Bond Lipton India, and as Vice Chairman of Hindustan Unilever Limited, After his Unilever career, he joined Tata Sons as a Director. He retired from TATA in December 2015 and currently serves as an Independent Director on the boards of the Indian subsidiaries of Akzo Nobel and Castrol India, Mr. Gopatakrishnan studied physics at Calcutta University. Engineering at IIT Kharagpur and completed an Advanced Management Program at the Harvard Business School. He is a Past President of the All India Management Association.

  • DR. ANURA EKANAYAKE

    Independent Director

    -

    Dr. Anura Ekanayake is a former Chairman of the Ceylon Chamber of Commerce, the Industrial Association of Sri Lanka and The International Natural Rubber Council. He has had an illustrious career in public service serving as a Senior Economist of the Mahaweli Authority, Director on the Boards of the State Plantations Corporation and JEDB, Director of Planning to the Ministry of Plantation Industries and Director General of the Ministry of Public Administration. Dr. Ekanayake held directorships in all 23 regional plantations companies and also served on the Tea Research Board, Postgraduate Institute of Agriculture and Plantation Housing and Social Welfare Development Trust. He Left his two decade Long public service and joined Unilever Sri Lanka and served as Director - Human Resources and Corporate Relations for 8 years. He serves at present on a number of boards of listed companies and non-Listed companies. Dr. Ekanayake, holds a B.A. (Horns) and MSc (Agriculture) from the University of Peradeniya and a Ph.D in Economics from the Australian National University. He is also a Fellow Member of the Institute of Certified Professional Managers. Dr. Ekanayake is a firm advocate of developing human capital and people transformation.

  • SAKTHA AMARATUNGA

    Independent Director

    -

    Mr. Saktha Amaratunga joined the Board in January 2016. Mr. Amaratunga is currently a Commissioner of PT Agro Indomas Indonesia and is also a Member of the Upstream and Downstream Audit Sub Committee of Goodhope Asia Holdings Ltd a subsidiary of the Carson Cumberbatch Group. He was previously Regional Audit Controller (Asia Pacific) for British American Tobacco. He has more than 20 years' experience with British American Tobacco. having performed senior finance roles for the Group in Sri Lanka and the United Kingdom. and also being the Finance Director of British American Tobacco operations in the Czech Republic, Sri Lanka, Switzerland, Japan and Malaysia (IT Shared Services Organisation). He has many years of experience in Strategy Development, Business Restructuring, Risk and Governance, International Finance and People Development. He is a Fellow Member of the Chartered Accountants of Sri Lanka, Associate Member of the Chartered Institute of Management Accountants, UK and also a Member of CPA Australia.

  • JYOTINDRA MANIBHAI TRIVEDI

    Independent Non-Executive Director

    -

    Mr Jyotindra Trivedi has more than 35 years of experience in Indian financial services industry and more than 25 years with Indian Venture Capital and Private Equity Industry. Mr Trivedi joined CDC, a UK based development finance institution, in 1997 to set up its Mumbai office. He was one the founding partners when Actis LLP was spun out of CDC in 2004. He took over Leadership of Actis South Asia in 2007. Mr Trivedi retired from Actis in 2017. By 2017. Actis had raised more than US$12bn since it was formed in 2004. As a member of global. investment committee of Actis Mr Trivedi had an overview of the investment activity of Actis across its key markets such as China, South Asia, Africa and Latin America and its key sectors such as Consumer, Healthcare, FinanciaL Services and Industrial. Mr Trivedi has been involved in numerous investments of Actis in India, most notabLy India Infoline(IIFL), Glenmark Pharmaceuticals, UTI Bank(now Axis Bank), Sterling Hospitals, Paras Pharmaceuticals and Avtec many of which have grown into Large businesses with leadership position in their respective sectors. Prior to Joining CDC, Mr Trivedi was senior vice president of GVFL, one of the first VC funds India. Mr Trivedi was part of the founding team of GVFL when it was set up in 1990 and was involved with its first three funds which focused on technology based start-up and early stage companies. Prior to joining GVFL he worked with GIIC, a development bank and AtuL Products, a dyes and intermediates conglomerate. Mr Trivedi graduated as a chemical engineer from the Indian Institute of Technology, Bombay and holds a Diploma in Finance from the Institute of Chartered Financial Analysts of India. Mr Trivedi currently serves on the board of Ostro Energy Private Limited which is an Actis owned company and is building a clean energy platform with Wind and Solar assets of more than 1000mw capacity in India.

  • Prof. Nilanthi Renuka De Silva

    Independent Non-Executive Director

    -

    Prof de Silva had her primary and secondary education at CMS Ladies College, Colombo. She graduated MBBS from the University of Colombo in 1986 and went on to obtain a Masters in Medical Parasitology from the London School of Hygiene and Tropical Medicine, UK and MD and Board Certification in Medical Parasitology, from Colombo University’s Postgraduate Institute of Medicine. She was a Commonwealth Fellow at the University of Oxford, UK in 1995/96, and a FAIMER Fellow at the George Washington University School of Medicine in Washington DC, USA, in 2004/05. She is an expert advisor on Neglected Tropical Diseases to the World Health Organization, serving both WHO Headquarters and the South East Asia Regional Office in many different capacities since 2000. Following an enriching career in the medical industry, Prof de Silva was appointed as the Dean of the Faculty of Medicine, University of Kelaniya from 2012 to 2018. At present she serves as the Chairman of the Board of Trustees of the Ayati Trust Sri Lanka, a collaborative partnership between the University of Kelaniya and multiple corporates in Sri Lanka, which aims to establish a national centre of excellence to serve children with disabilities.

BOARD OF
MANAGEMENT
  • Murtaza Esufally

    Executive Director

    -

    Mr. Murtaza Esufally counts more than 25 years of experience in senior management levels. He is the Chairman of Hemas Hospitals (Pvt) Ltd and Hemas Pharmaceuticals (Pvt) Ltd, and is the Non-Executive Chairman of the Centre for Poverty Analysis. He holds a Master's Degree in Business Administration from the Melbourne Business School of the University of Melbourne, He is a Barrister of the Lincoln's Inn and holds a Bachelor of Law Degree from the University of Essex, UK. Mr. Esufally is an Attorney-at-Law of the Supreme Court of Sri Lanka.

  • Kasturi Chellaraja Wilson

    Deputy CEO

    -

    Kasturi is the Managing Director of Hemas Pharmaceuticals and the Group’s Logistics and Maritime sectors. She is a Fellow of the Chartered Institute of Management Accountants, UK and has served as Board Member of CIMA, Sri Lanka. She counts for over 29 years of managerial experience in multiple industries and functions spanning from auditing, consulting, logistics, leisure and travel and pharmaceuticals. Kasturi joined Hemas in 2002 as the Finance Director of Hemtours (Presently, Diethelm Travel) and in 2005 she was appointed the Head of Shared Services for the Group and subsequently as the Chief Process Officer of the Group in 2007. In 2011 she was appointed as the Managing Director of the Transportation Sector and in 2016, Managing Director of the Pharmaceutical Distribution Business. In 2017 she was appointed a Non-Independent Non-Executive Director of Morison PLC and in 2018 as a Non-Executive of Capital Alliance Ltd. Kasturi is also a member of the Economic Policy Committee of the Ceylon Chamber of Commerce.

  • ROY JOSEPH

    Managing Director of Hemas Manufacturing (Pvt) Ltd

    -

    Roy is the Managing Director of Hemas Manufacturing (Pvt) Ltd. He is a Fellow of the Chartered Institute of Management Accountants of UK, a Fellow of the Institute of Certified Management Accountants of Sri Lanka and he holds a Postgraduate Diploma in Finance & Business Administration from the Institute of Chartered Accountants. He counts over 20 years of management experience in the fields of Finance, IT, Supply Chain, Channels/Customer Development and General Management. He has held key positions in several FMCG, Plantations, Construction and Logistics companies.

  • Sriyan De Silva Wijeyeratne

    Managing Director -FMCG Sri Lanka

    -

    Sriyan was the Managing Director / CEO of Teejay Lanka PLC, which is one of the S&P Top 20 Companies and was recognized during his time as a Winner of Forbes “Asia’s 200 Best under a Billion Dollar Company”. He served as Country Manager of Microsoft, was Director Marketing and Sales of Suntel, previously at Nestles and more recently was Group CEO for the conglomerate Abans. He is currently the Chairman of the Employees Trust Fund Board. He has several academic and business awards to his credit and is a frequent speaker at leading forums locally and globally. He was previously named CIMA Business Manager of the Year and is involved in many Chambers and local and global charities. He possesses a First Class in Business Administration from the University of Sri Jayawardenapura, a Masters Degree from the same university, and has had Executive education at many global institutions including INSEAD and CCL. He is a Fellow member of CIMA, UK, and is also a CGMA. He was on the International Board of Youth Business International, which is one of Prince Charles’ Charities based out of UK and has served on several local Boards. He is President of the Wildlife and Nature Protection Society and passionate about travelling, music, Community work and photography.

  • LAKITH PEIRIS

    Managing Director, Hemas Hospitals

    -

    Lakith joined Hemas on 01st April 2015. He is a well-known leader in the Healthcare industry having been the CEO of one of the most successful city hospitals over the past 7 years. He has over 20 years' experience in top management at a host of healthcare related MNCs including BiBraun Asia Pacific, Lifesery and ConvaTec A Bristol Myers Squibb Company of USA amongst others. He holds a Doctorate in Business & Management, an MBA from University of Western Sydney, Australia, and is a Certified Professional Marketer from the Asia Pacific Marketing Federation and holds a Postgraduate DipLoma in Marketing from the Sri Lanka Institute of Marketing. Lakith has memberships in several professionaL Associations and Federations. He is a Member of the Private Health Services Regulatory Council of the Ministry of Health and also serves the Regulatory CounciL in various sub-committees.

  • Steven Enderby

    Executive Director / CEO

    -

    Mr. Steven Enderby joined Hemas in March 2013 to head the Group's efforts in Mergers and Acquisitions. He took up the Office of Deputy CEO and Director of Hemas Holdings PLC in November 2013 and was appointed the Chief Executive Officer of the Company on 01st April 2014. Mr. Enderby has had a successful track record in the private equity space with Actis, a leading global emerging markets fund, until his retirement in 2011 as an Actis Partner. Some of the most successful private equity transactions he led include South Asia Gateway Terminal. Ceylon Oxygen and Millennium Information Technologies. He has also served on the Boards of leading companies in Sri Lanka and India such as John Keells Holdings, Lion Brewery and Punjab Tractors. He is a Fellow of the Chartered Institute of Management Accountants, and holds a Degree in Economics and Accounting from Queens University Belfast, and a Master's Degree in Development Studies from the University of Melbourne.

  • RUWANI HETTIARACHCHI

    Chief Growth Officer

    -

    Prior to her role in Hemas, Ruwani was the CEO and Founder of Vox & Co. a boutique strategy consultancy firm and was Head of Research & Consulting at Stax, a U.S. based strategy consulting firm for 6 years. Ruwani is on the board of two of Hemas Digital Healthcare startups. She previously served on the board of Colombo Academy of Hospitality Management at SLIIT. Ruwani has an MA in Economics from the University of Edinburgh.

  • Asitha Samaraweera

    Managing Director Atlas Axillia

    -

    Asitha Samaraweera currently is the Managing Director of Atlas Axillia Co Ltd., a Hemas Holdings group company. Atlas Axillia Co Ltd is one of Sri Lanka’s most respected local brands and is a market leader in school stationery and notebooks, pens, pencils and colour products, with products retailed in over 70,000 outlets across Sri Lanka.

    Before his current role he counts over 12 years’ experience in leading FMCG businesses both in Sri Lanka and overseas. Asitha was the CEO of CBL Cocos (Pvt) Ltd., and CBL Global Foods, both subsidiaries of Ceylon Biscuits Limited before joining Atlas Axilla. The company was a leading player in the coconut products industry with a substantial export interest.

    Prior to his role at CBL, Asitha headed IFFCO (Frozen Foods) and GFI – leading Dubai-based FMCG companies for six years. The two companies are leading processed meat and frozen bakery product manufactures in the Middle East.

    Prior to his stint in the middle east he served as CEO of Keells Food Products and Vice President at John Keells Holdings PLC. Keells food Products PLC is the leading processed food manufacturer and marketer in Sri Lanka.

    Asitha began his career with Nestle joining as a management training and rising in the ranks in the marketing arena. In his career in marketing he was involved in many successful campaigns which included the Nestomalt’s defeat of Powermalt which is now a well know case study.

    He has a background in Marketing with an MSc in International Accounting and Finance, London School of Economics one of the leading universities in the world. He also has a BSc in Business Administration, Washington University, St Louis, MO, USA. His Schooling was at St Thomas College, Mount Lavinia.

  • Zalmi Fazeel

    Group Chief Financial Officer

    -

    Mr. Zalmi Fazeel has served as an Executive Vice President heading the finance, legal and IT operations of Saudi Cable Company, Saudi Arabia between 2013 and 2017. He served at the Savola Group, Saudi Arabia, between 2000 and 2013 in various roles, including that of Executive Director-Group Treasury, Chief Financial Officer of Edible Oil Subsidiaries, Head of Finance and IT at the United Sugar Company, and Head of Finance Shared Services. He started his career at Pfizer Sri Lanka currently known as Astron Limited, in 1984. He was appointed to the Board of Astron in 1992, which position he held until he moved to Saudi Arabia in January 2000. He was an independent Board member and Chaired the Audit committee of Hemas Hospitals (Pvt) Limited, from March 2017 to July 2018. At present he serves the Board of Hemas Hospitals (Pvt) Ltd as a Non- Executive Director. He is a Fellow of the Chartered Institute of Management Accountants (UK). Mr. Zalmi Fazeel has been appointed as the Group Chief Financial Officer of Hemas Holdings PLC w.e.f 1st September 2018.

    Mr. Zalmi Fazeel has been appointed as the Group Chief Financial Officer of Hemas Holdings PLC w.e.f 1st September 2018.